BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 8505613)

  • 1. Office of Inspector General U.S. Department of Health and Human Services. An overview.
    Federgreen WR
    J Fla Med Assoc; 1993 Apr; 80(4):236-40. PubMed ID: 8505613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fighting Medicare and Medicaid fraud and abuse.
    Kusserow RP
    Internist; 1990 Jun; 31(6):6-7, 14. PubMed ID: 10112281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exchanges on HHS inspector general's agenda.
    Levinson D; Carlson J
    Mod Healthc; 2014 Jun; 44(23):31. PubMed ID: 25016889
    [No Abstract]   [Full Text] [Related]  

  • 4. Consolidated billing and compliance program--Part 2.
    Stahl DA
    Nurs Manage; 1998 Jun; 29(6):12-5. PubMed ID: 9807420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inspector General Kusserow tracks fraud, abuse, and waste. Interview by Jane Stein.
    Kusserow RP
    Bus Health; 1986 Dec; 4(2):40-2. PubMed ID: 10301170
    [No Abstract]   [Full Text] [Related]  

  • 6. Medicare and state health care programs: fraud and abuse; safe harbors for protecting health plans--Office of Inspector General, HHS. Final rule.
    Fed Regist; 1996 Jan; 61(17):2122-37. PubMed ID: 10155826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare and state health care programs and program fraud civil remedies: fraud and abuse; civil money penalties inflation adjustments--Office of Inspector General, HHS. Final rule.
    Fed Regist; 1996 Oct; 61(195):52299-301. PubMed ID: 10162168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new health insurance act: a powerful weapon for fighting fraud and abuse.
    Scott JS
    Healthc Financ Manage; 1996 Nov; 50(11):24, 26. PubMed ID: 10162343
    [No Abstract]   [Full Text] [Related]  

  • 9. The future of American medicine.
    Roper WL
    Ala Med; 1988 May; 57(11):21-2, 25-8. PubMed ID: 3291591
    [No Abstract]   [Full Text] [Related]  

  • 10. HHS Inspector General publishes final safe harbor regulations.
    Valiant C
    Physician Exec; 1991; 17(5):34-6. PubMed ID: 10114719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Office of inspector general; statement of organization, functions and delegations of authority--HHS.
    Fed Regist; 1997 Oct; 62(208):55810-5. PubMed ID: 10177305
    [No Abstract]   [Full Text] [Related]  

  • 12. Medicare and state health care programs: fraud and abuse; issuance of advisory opinions by the OIG--HHS. Interim final rule with comment period.
    Fed Regist; 1997 Feb; 62(33):7350-60. PubMed ID: 10165201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DHHS Office of Inspector General: an overview.
    Hsia D
    R I Med J (1976); 1989 Feb; 72(2):47-55. PubMed ID: 2928684
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost of hospital and medical care and treatment furnished by the United States; certain rates regarding recovery from tortiously liable third persons--OMB.
    Fed Regist; 1995 Nov; 60(229):61450-2. PubMed ID: 10152772
    [No Abstract]   [Full Text] [Related]  

  • 15. Health care programs; fraud and abuse; amendments to OIG exclusion and CMP authorities resulting from Public Law 100-93-- Office of Inspector General, HHS. Final rule and clarification.
    Fed Regist; 1993 Jan; 58(13):5617-8. PubMed ID: 10123773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible changes in store for PRO program.
    Harrop DE
    Pa Med; 1992 Jul; 95(7):34. PubMed ID: 1408266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health care programs: fraud and abuse; revisions to the PRO sanctions process--HHS. Final rule.
    Fed Regist; 1995 Dec; 60(238):63634-45. PubMed ID: 10153804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventional pain management at crossroads: the perfect storm brewing for a new decade of challenges.
    Manchikanti L; Singh V; Boswell MV
    Pain Physician; 2010; 13(2):E111-40. PubMed ID: 20309388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How far can providers go? Regulators grapple with antitrust, fraud-and-abuse issues under reform.
    Blesch G
    Mod Healthc; 2010 Sep; 40(38):36-7. PubMed ID: 20936766
    [No Abstract]   [Full Text] [Related]  

  • 20. WIPRO clarifies changes to quality review process.
    Wis Med J; 1993 Aug; 92(8):479. PubMed ID: 8237040
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.